Edwards Lifesciences Corporation Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.74B | 1.65B | 1.57B | 1.55B | 1.53B | 1.41B | 1.39B | 1.35B |
| Cost of Goods Sold | 390.6M | 359.3M | 340.6M | 345.2M | 342.6M | 301.6M | 292.2M | 262.9M |
| Gross Profit | 1.35B | 1.29B | 1.23B | 1.21B | 1.19B | 1.11B | 1.09B | 1.09B |
| R&D Expenses | 278.9M | 263.3M | 267.7M | 280.7M | 276.2M | 254.6M | 271.1M | 253.4M |
| Operating Expenses | 830.9M | 774.6M | 858.7M | 784.5M | 758.7M | 716.3M | 781.0M | 740.9M |
| Operating Income | 519.5M | 514.7M | 370.3M | 425.1M | 430.9M | 394.8M | 312.6M | 350.6M |
| Other Income / Gains | 300K | -55.7M | -279.9M | -76.7M | -30.7M | 39.1M | 77.5M | 52.2M |
| Net Income | 241.9M | 380.7M | 91.2M | 291.1M | 329.8M | 358.0M | 385.6M | 3.07B |
| EPS (Diluted) | 0.42 | 0.66 | 0.16 | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.776 | 0.782 | 0.783 | 0.779 | 0.776 | 0.787 | 0.789 | 0.806 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 561.2M | 522.2M | 602.9M | 514.6M | 502.0M | 465.7M | 491.9M | 421.4M |
| Other Expenses | -9.2M | -10.9M | -11.9M | -10.8M | -19.5M | -4.0M | 18.0M | 66.1M |
| Cost And Expenses | 1.22B | 1.13B | 1.20B | 1.13B | 1.10B | 1.02B | 1.07B | 1.00B |
| Interest Income | 30.0M | 33.5M | 35.9M | 38.6M | 37.4M | 19.5M | 44.2M | 23.5M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 40.9M | 42.7M | 39.2M | 38.1M | 36.6M | 42.6M | 34.5M |
| Ebitda | 519.5M | 499.9M | 133.1M | 387.6M | 400.2M | 470.5M | 483.7M | 428.8M |
| Ebitdaratio | 0.298 | 0.303 | 0.085 | 0.25 | 0.261 | 0.333 | 0.349 | 0.317 |
| Operating Income Ratio | 0.298 | 0.312 | 0.236 | 0.274 | 0.281 | 0.279 | 0.226 | 0.259 |
| Income Before Tax | 519.8M | 459.0M | 90.4M | 348.4M | 400.2M | 433.9M | 390.1M | 402.8M |
| Income Before Tax Ratio | 0.299 | 0.278 | 0.058 | 0.224 | 0.261 | 0.307 | 0.281 | 0.297 |
| Income Tax Expense | 278.4M | 78.3M | 26.2M | 56.1M | 64.3M | 70.3M | 45.1M | 40.7M |
| Net Income Ratio | 0.139 | 0.231 | 0.058 | 0.187 | 0.215 | 0.253 | 0.278 | 2.267 |
| Epsdiluted | 0.42 | 0.66 | 0.16 | 0.50 | 0.56 | 0.61 | 0.65 | 5.13 |
| Weighted Average Shs Out | 576.4M | 579.2M | 580.4M | 584.7M | 587.0M | 586.9M | 589.8M | 597.2M |
| Weighted Average Shs Out Dil | 577.6M | 580.7M | 581.8M | 585.7M | 587.9M | 587.8M | 590.5M | 598.1M |